595 nm脉冲染料激光器治疗婴幼儿浅表血管瘤的临床疗效及影响因素分析  

Analysis on the clinical efficacy and influencing factors of Vbeam 595 nm pulsed dye laser in the treatment of superficial IHs

作　　者：王思[1] 刘春景[1] 邢小光 常露 Wang Si;Liu Chunjing;Xing Xiaoguang;Chang Lu(Department of Dermatology,Tangshan Maternal and Child Health Care Hospital,Tangshan 063000,China)

机构地区：[1]唐山市妇幼保健院皮肤科,唐山063000

出　　处：《中国医学装备》2024年第8期96-100,共5页China Medical Equipment

基　　金：河北省科技计划项目(192777149)。

摘　　要：目的:回顾性研究Vbeam 595 nm脉冲染料激光器(PDL)治疗婴幼儿血管瘤(IHs)中期临床效果,分析探索其可能的影响因素。方法:收集2020年1月至2022年12月唐山市妇幼保健院行PDL治疗的219例IHs患儿,并至少随访6个月,分析治疗效果与月龄、血管瘤部位、厚度及治疗次数等之间的关系。结果:219例患儿总体中位月龄7个月,平均月龄(4~10)个月,总计219处病损。月龄、病损特征等一般资料在性别间差异无统计学意义(P>0.05)。治疗总体有效率92.7%,中位治疗次数3次,平均(2~4)次。男女性别间比较、治疗次数及治疗结局差异无统计学意义(P>0.05)。疗效差的6人,月龄13(8,19)个月;疗效一般的10人,月龄13(8,14)个月;疗效好的31人,月龄8(4,10)个月;疗效优的172人,月龄6(4,9)个月;不同疗效患儿间月龄差异具有统计学意义(Z=24.863,P<0.001),疗效优的患儿月龄较小。血管瘤患儿的治疗结局与其病变厚度、面积大小及治疗次数有相关性(r=-0.32、-0.46、-0.46,P<0.05),治疗有效主要集中在2~4次的治疗中。治疗引起的不良反应为皮肤红斑,总体半年后残留并发症率为5.48%。结论:595 nm PDL联合动态冷却装置(DCD)治疗为IHs提供了一种安全、有效的治疗方式,在早期对IHs进行干预,可以提高治疗效果,减少治疗疗程,从而进一步减少相应并发症可能。Objective:To retrospectively study the curative effect of Vbeam 595nm pulsed dye laser(PDL)in treating the mid-term infantile hemangiomas(IHs),and analyze and explore the possible influencing factors of that.Methods:A total of 219 IHs patients who underwent PDL treatment in Tangshan Maternal and Child Health Care Hospital from January 2020 to December 2022 were selected,and they received follow-up at least 6 months.The relationship between the treatment effect and the month age,location,thickness of hemangioma and the number of treatments was analyzed.Results:The median month age of the 219 pediatric children was 7 months,and the average month age of them was(4-10)months,and there was a total of 219 lesions.There were no statistically significant differences in the general data such as month age and the characteristics of lesion between different genders(P>0.05).The overall effective rate of treatment was 92.7%,and the median number of treatments was 3 times,and the average number of treatments was(2-4)times.There were no statistically significant differences in the comparisons of gender,the number of treatments and the treatment outcome(P>0.05).The curative effects of 6 pediatric children were poor,whose month age was 13(8,19)months.The curative effects of 10 pediatric children were general,whose month age was 13(8,14)months.The curative effects of 31 pediatric children were favorable,whose month age was 8(4,10)months.The curative effects of 172 pediatric children were excellent,whose month age was 6(4,9)months.The difference of month age of pediatric children among different curative effect was significant(Z=24.863,P<0.001),and the pediatric children with better curative effect had smaller month age.The treatment outcome of pediatric children with hemangioma was correlated with the thickness of lesion,the area size of lesion and the number of treatment(r=-0.32,-0.46,-0.46,P<0.05),respectively.The effective treatment mainly focused on the treatments of the 2nd-4th times.The adverse reaction caused by treatment w

关 键 词：婴幼儿血管瘤(IHs) 脉冲染料激光器(PDL) 临床效果 影响因素 

分 类 号：R732.2[医药卫生—肿瘤]